v3.26.1
COMBINED AND CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Class A-1 Shares
Total Stockholders' Equity
Class A-1 Shares
Parent's Net Investment
Class A-1 Shares
Common Stock
Class A-1 Shares
Additional Paid-In Capital
Class A-1 Shares
Cumulative Dividends In Excess Of Earnings
Class A-1 Shares
Common Units of Janus OP, LLC, held by Healthpeak Properties, Inc.
Class A-1 Shares
Other Noncontrolling Interests
Class A-1 Shares
Class A-2 Shares
Total Stockholders' Equity
Class A-2 Shares
Parent's Net Investment
Class A-2 Shares
Common Stock
Class A-2 Shares
Total Stockholders' Equity
Parent's Net Investment
Additional Paid-In Capital
Cumulative Dividends In Excess Of Earnings
Common Units of Janus OP, LLC, held by Healthpeak Properties, Inc.
Other Noncontrolling Interests
Total
Beginning balance at Dec. 31, 2024                                     $ 1,308,853
Increase (Decrease) in Stockholders' Equity                                      
Net income (loss)                                     (2,110)
Net distributions to Parent                                     (3,221)
Ending balance at Mar. 31, 2025                                     1,303,522
Beginning balance at Dec. 31, 2024                                     1,308,853
Increase (Decrease) in Stockholders' Equity                                      
Net income (loss)                                     6,349
Net distributions to Parent                                     (32,892)
Ending balance at Dec. 31, 2025     $ 0               $ 0   $ 1,282,310 $ 1,282,310 $ 0 $ 0 $ 0 $ 0 1,282,310
Ending balance (in shares) at Dec. 31, 2025     0         0     0 0              
Increase (Decrease) in Stockholders' Equity                                      
Net income (loss) $ 31,332 $ 39,888     $ (8,556) $ (3,467) $ 9 $ 27,874                     27,874
Net contributions from Parent                 $ 837,092 $ 837,092   $ 837,092              
Issuance of common stock in connection with initial public offering, net of underwriting fees and offering costs $ 131,690 $ (2,159,290) $ 1,872 $ 2,289,108       $ 131,690 $ 759   $ 759 $ 759              
Issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions and offering costs (in shares)     187,223,000               75,918,000                
Issuance of noncontrolling interests in connection with initial public offering                                 763,401 2,737 766,138
Stock-based compensation                         16   16     18 34
Acquisition of noncontrolling interests                                   345 345
Distributions to noncontrolling interests     $ 0               $ 0   0 0 0 0 0 (354) (354)
Adjustments to noncontrolling interests                         (118,395)   (118,395)   118,395    
Ending balance at Mar. 31, 2026     $ 1,872               $ 759   $ 2,164,804 $ 0 $ 2,170,729 $ (8,556) $ 878,329 $ 2,755 $ 3,045,888
Ending balance (in shares) at Mar. 31, 2026     187,223,000         187,222,996     75,918,000 75,917,780